MENU
MRNS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Marinus Pharmaceuticals (MRNS) Ownership - Who owns Marinus Pharmaceuticals?

Profile

Industry
Pharmaceuticals Other
Address
100 Matsonford Road
Phone
+1 484 801-4670
Employees
165
Web
https://www.marinuspharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
13.66M
P/E Ratio
N/A
Total Cash
1.42M
Projected Growth
N/A
Total Debt
75.36M
Revenue
N/A
Risk (Beta)
2.09
Dividend Yield
N/A
Total Cash/Share
0.03
Total Debt/Equity
N/A
Revenue/Share
0.55 USD as % of share price

Fundamentals

MRNS
Capitalization
13.7M
P/E Ratio
N/A
Risk (Beta)
2.09
Dividend Yield
N/A
Total Cash
1.42M
Total Cash/Share
0.03
Total Debt
75.4M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.55%
Revenue
N/A
ROE
N/A
Book Value
-16.43M
P/B Ratio
5.14
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
55K
Current Ratio
3.07
Current Revenue Per Employee
46259.04
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
90.16
Revenue To Assets
N/A
Shares Held By Institutions
71.4M
Shares Outstanding - Current
55.2M
Total Liabilities
154M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-97.728
View a ticker or compare two or three
MRNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of innovative neuropsychiatric therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
100 Matsonford Road
Phone
+1 484 801-4670
Employees
165
Web
https://www.marinuspharma.com